california biotechnology inc said expects report loss 300 000 dlrs 600 000 dlrs for first quarter due increased investment research and manufacturing and scaleup production company said research spending running pct above year ago tries commercialize its products quickly possible and increased expenditures expected continue for several more quarters said operating results will fluctuate quarter quarter depending timing significant payments from commercial partners first three months 1986 company lost 150 000 dlrs company changed its fiscal year 1986 calendar year from year ending november for first quarter last year ended february california biotech earned 114 000 dlrs reuter 